Yiyin Cao

Orcid: 0000-0002-3481-8930

According to our database1, Yiyin Cao authored at least 13 papers between 2021 and 2026.

Collaborative distances:
  • Dijkstra number2 of four.
  • Erdős number3 of four.

Timeline

Legend:

Book  In proceedings  Article  PhD thesis  Dataset  Other 

Links

On csauthors.net:

Bibliography

2026
Characterization and Computation of Normal-Form Proper Equilibria in Extensive-Form Games via the Sequence-Form Representation.
CoRR, February, 2026

2025
Optimal reward-based crowdfunding with co-creation.
J. Oper. Res. Soc., November, 2025

A sequence-form differentiable path-following method to compute Nash equilibria.
Comput. Optim. Appl., September, 2025

A Sequence-Form Characterization and Differentiable Path-Following Computation of Normal-Form Perfect Equilibria in Extensive-Form Games.
CoRR, May, 2025

Variants of Harsanyi's tracing procedures for selecting a perfect stationary equilibrium in stochastic games.
Comput. Oper. Res., 2025

2024
How the agency contract fails in hybrid mode: agency fees and distribution sequences.
Int. Trans. Oper. Res., November, 2024

A Variant of the Logistic Quantal Response Equilibrium to Select a Perfect Equilibrium.
J. Optim. Theory Appl., June, 2024

A Differentiable Path-Following Method with a Compact Formulation to Compute Proper Equilibria.
INFORMS J. Comput., 2024

2022
Complementarity Enhanced Nash's Mappings and Differentiable Homotopy Methods to Select Perfect Equilibria.
J. Optim. Theory Appl., 2022

A variant of Harsanyi's tracing procedures to select a perfect equilibrium in normal form games.
Games Econ. Behav., 2022

A differentiable path-following method to compute subgame perfect equilibria in stationary strategies in robust stochastic games and its applications.
Eur. J. Oper. Res., 2022

2021
Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer.
Briefings Bioinform., July, 2021

Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer.
Briefings Bioinform., 2021


  Loading...